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Abstract
Mycobacterium abscessus has emerged as an important cause of lung infection, particularly in patients with bronchiectasis.
Innate immune responses must be highly effective at preventing infection with M. abscessus because it is a ubiquitous
environmental saprophyte and normal hosts are not commonly infected. M. abscessus exists as either a glycopeptidolipid
(GPL) expressing variant (smooth phenotype) in which GPL masks underlying bioactive cell wall lipids, or as a variant lacking
GPL which is immunostimulatory and invasive in macrophage infection models. Respiratory epithelium has been
increasingly recognized as playing an important role in the innate immune response to pulmonary pathogens. Respiratory
epithelial cells express toll-like receptors (TLRs) which mediate the innate immune response to pulmonary pathogens. Both
interleukin-8 (IL-8) and human b-defensin 2 (HbD2) are expressed by respiratory epithelial cells in response to toll-like
receptor 2 (TLR2) receptor stimulation. In this study, we demonstrate that respiratory epithelial cells respond to M. abscessus
variants lacking GPL with expression of IL-8 and HbD2. Furthermore, we demonstrate that this interaction is mediated
through TLR2. Conversely, M. abscessus expressing GPL does not stimulate expression of IL-8 or HbD2 by respiratory
epithelial cells which is consistent with ‘‘masking’’ of underlying bioactive cell wall lipids by GPL. Because GPL-expressing
smooth variants are the predominant phenotype existing in the environment, this provides an explanation whereby initial
M. abscessus colonization of abnormal lung airways escapes detection by the innate immune system.
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Introduction
Mycobacterium abscessus, a nontuberculous mycobacterium, is an
important emerging pathogen causing fibrocavitary lung disease
which is often indistinguishable from disease caused by M.
tuberculosis [1–3]. It is also an emerging infection in patients with
cystic fibrosis [4–7]. Unlike M. tuberculosis, M. abscessus has the
ability to express glycopeptidolipid (GPL) in the outer cell wall.
Expression of GPL, or lack thereof, is correlated with the smooth
or rough colony phenotype respectively, which is observed in
certain species of nontuberculous mycobacteria [8]. GPL-mediat-
ed biofilm formation is felt to facilitate survival in the environment
and we have postulated that it may facilitate colonization of ectatic
lung airways [8]. Spontaneous loss of GPL by M. abscessus is
associated with acquisition of an invasive, immunostimulatory
phenotype [8,9]. We have proposed that loss of GPL ‘‘unmasks’’
underlying bioactive cell wall lipids which mediate virulence [8,9].
Recently we deleted the gene mmpL4b, a gene coding for a critical
enzyme in the biosynthetic GPL pathway [10,11], from the well
characterized M. abscessus GPL-expressing variant 390S [8,9,12].
Assessing the interaction of this deletion mutant with human
monocyte-derived macrophages, we demonstrated that loss of
GPL is sufficient to convert this M. abscessus variant to a phenotype
which is able to replicate in these cells and stimulate their toll-like
receptors (TLRs) [13].
M. abscessus primarily causes lung disease in individuals who are
immunosuppressed, or who have abnormal lung airways. Because
M. abscessus is ubiquitous in the environment, innate immune
responses must be highly effective in preventing infection as
normal hosts are uncommonly infected. TLRs recognize patho-
gen-associated molecular patterns and are the transducers of the
innate immune response [14]. Mononuclear phagocytes have been
extensively studied in terms of their TLR responses because they
are actively involved in surveillance at the interface of the mucosal
surfaces and the environment. Additionally, it has been recognized
that respiratory epithelial cells lining the lung airways also play a
critical role in surveillance and the innate immune response [15].
An important downstream effect of TLR signaling in respiratory
epithelial cells is release of the chemokine interleukin-8 (IL-8)
which recruits neutrophils from the circulation to the site(s) of
TLR activation in the lung airways. As such, IL-8 release into cell
supernates has been used as readout for TLR stimulation in
experiments examining TLR responses of respiratory epithelial
cells cultured in vitro. Human b-defensin (HbD2) is an antimicro-
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e29148bial peptide known to be upregulated in respiratory epithelial cells
by TLR signaling [16]. In this study we demonstrate the utility of
measuring HbD2 gene expression, as well as IL-8 release, as
readouts of respiratory epithelial cell responses to M. abscessus.
Using these assays, we demonstrate that respiratory epithelial cell
TLRs do not recognize the colonizing phenotype of M. abscessus
which expresses GPL, and that loss of GPL through targeted
deletion of the mmpLb4 gene converts M. abscessus to a phenotype




The isogenic M. abscessus 390S (smooth colony morphotype
expressing GPL), 390R and 390V (rough colony morphotype
lacking GPL expression) variants have been previously character-
ized [8,9,12,17]. The mmpL4b gene deletion mutant derived from
the 390S variant, and the mmpL4b complemented mutant have been
described in a recent publication [13]. Bacteria were maintained as
titrated frozen stocks stored at 270u C with intermittent passage for
3 days on Middlebrook 7H11 agar plates supplemented with
Middlebrook OADC (BD), followed by flash freezing. To prepare
single-cell frozen bacterial stocks for experiments, lawns of the
different bacterial strains were plated on Middlebrook 7H11
OADC agar plates and incubated at 37u C. After 3 days, bacteria
were harvested and placed into sterile Eppendorf tubes containing
1.0 mL sterile PBS and three glass beads. Tubes were pulse-
vortexed 50 times, after which residual aggregates of bacteria were
allowed to settle for 20 min. The top 500 mL of bacterial supernate
wasremovedand the supernates from twoto four tubes were pooled
in 50 mL conical tubes. Bacteria were then sonicatedon high power
in a sonicating waterbath for 20 s to break apart any residual
bacterial aggregates. The bacterial suspension was aliquoted into
multiple Eppendorf tubes, which were then flash frozen and stored
at 270u C. Individual tubes were thawed and titrated to determine
CFU for a particular frozen stock.
Infection of A549 cells for measurement of HBD2 gene
expression and IL-8 levels
The A549 cell line is a well characterized Type II alveolar
epithelial tumor cell line which was obtained from the American
Type Culture Collection (Rockville, MD). A549 cells were
cultured in Dulbecco’s Modified Eagle Medium (DMEM) (Sigma)
with 10% Fetal Bovine Serum (FBS)(Invitrogen) and 1%
Antibiotic-Antimycotic (Gibco) at 37uCi n5 %C O 2. All experi-
ments were performed prior to the twenty fifth cell passage. A549
cells were plated at 1.5610
5 cells/mL, in a volume of 3 mL of
DMEM+10% FBS+1% Antibiotic-Antimycotic in 6-well tissue
culture treated plates (Greiner) and incubated for 72 h at 37uC, in
humidified 5% CO2. The cells were then washed 3 times with
3 mL Iscove’s Modified Dulbecco’s Medium (with sodium
bicarbonate; without L glutamine: Sigma), and the media was
replaced with 2 mL Iscoves+5% human serum (Human AB
Serum, male—SeraCare). Wells were infected with M. abscessus
variants at a concentration of 1610
7 CFU/well. Uninfected
control wells were left untreated or in some cases received either
100 ng/mL MALP-2 (TLR6/TLR2 ligand; Imgenex), or 20 ng/
mL recombinant human interleukin-1b (IL1ß) (PeproTech). The
plates were then incubated at 37uC, in humidified 5% CO2 for
8 hr. The wells were washed 3 times with 3 mL Iscove’s medium,
and 350 mL Qiagen RLT buffer (Qiagen) was added to the wells to
lyse the cells. Lysates were placed in RNAse free tubes (VWR) and
frozen 280uC for later RNA isolation.
For experiments measuring A549 IL-8 release, cells were plated
at a concentration of 5610
5 cells/mL using the same medium in
24-well tissue culture treated plates (Greiner), and incubated for
24 h at 37uC, in humidified 5% CO2. The cells were then washed
3 times with 0.5 mL Iscoves medium and the media replaced with
Iscoves medium alone. Wells then received medium alone, anti-
TLR2 antibody (10 mg/mL)(Ebioscience 16902483) or IgG1
isotype control antibody (10 mg/mL)(Ebioscience 16902483). After
a 1 h incubation, wells received no bacteria, or M. abscessus
variants at a concentration of 2.5610
6 CFU/well. After an
additional 8 hours the supernates were collected, filtered with
0.2 um centrifugal filters (VWR 82031-358), and frozen at
280uC. Supernates were analyzed per manufacturer’s protocol
with the BD Human IL-8 ELISA set (BD555244).
Infection of BEAS 2B cells for measurement of IL-8 levels
The BEAS 2B cell line, a well-characterized SV40 immortalized
cell line derived from normal human bronchial epithelium, was
obtained from the ATCC. These cells contain TLR1 through
TLR6 and respond to the TLR2 agonist Pam 3 Cys with expression
of IL-8 [18,19]. BEAS2b cells were plated at a concentration of
2610
5 cells per well in 0.5 mL BEBM+BEGM kit (without
gentamicin-amphotericin B) (Lonza cc3171 and cc3170), in 24-well
tissue culture plates coated with 0.01 mg/mL fibronectin, 0.3 mg/
mL bovine collagen type 1 and 0.01 mg/mL BSA in BEBM (Sigma
F1141; Advanced Biomatrix 5005-B; Sigma A9418), and incubated
at 37uC, 5% CO2 for 24 hours. The wells were rinsed 3 times with
BEBM and refilled with 0.5 mL BEBM. Wells then received
medium alone, anti-TLR2 antibody (10 mg/mL)(Ebioscience
16902483) or IgG1 isotype control antibody (10 mg/mL)(E-
bioscience 16902483). Wells were then incubated at 37uC, 5%
CO2 for 1 hour. After 1 h incubation, wells received no bacteria, or
M. abscessus variants at a concentration of 2.5610
6 CFU/well. After
an additional 8 hours, the supernates were collected and filtered
with 0.2 um centrifugal filters (VWR 82031-358) and frozen at
280uC. Supernates were analyzed per manufacturers protocol with
the BD Human IL-8 ELISA set (BD555244).
Real-time PCR assessment of HBD2 gene expression
RNA from lysates of A549 cells receiving various treatments was
isolated using the RNeasy kit (Qiagen). For HbD2, the primer/
probe sequences and final reaction concentrations were based on
previous reports, and were as follows: forward: 59-GAGGAGGC-
CAAGAAGCTGC-39 (300 nM); reverse: 59-CGCACGTCTCT-
GATGAGGG-39 (300 nM); probe: 59-FAM-TGGCTGATGCG-
GATTCAGAAAGGG-TAMRA-39 (250 nM) [16]. The ABI
Human Eukaryotic 18S rRNA TaqmanH Gene Expression Assay
(Endogenous Control) was used per the manufacturer’s instruction
for detection of 18S rRNA. qRTPCR of the RNA was performed
using the ABI TaqmanH One Step RT-PCR Master Mix Reagents
kit, per manufacturer’s instruction. A no template control was
included to verify that amplification only took place in reactions
containing RNA. Thermocycling conditions began with reverse
transcription, consisting of one cycle at 48uC for 30 minutes,
followed by one cycle at 95uC for 10 minutes. PCR consisted of 40
cycles at 95uC for 15 seconds, and 60uC for 60 seconds. Relative
quantity was determined using the 2
2DDCT method [20], using the
untreated control as the calibrator sample.
Assessment of the effect of siRNA TLR2 knockdown on
HBD2 expression in response to M. abscessus
Transfection of A549 cells was performed by plating at a
concentration of 4610
5 cells per well in 4 mL DMEM+10% FBS
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by incubation at 37uC in humidified 5% CO2 for 24 hours. The
cells were then washed 3 times with 2 mL 37u C PBS (Gibco),
followed by addition of 2 mL 37u C DMEM+10% FBS+1%
Antibiotic-Antimycotic to each well. The transfection solution was
created by combining 2.2 pmoles of either TLR2 Silencer Select
siRNA s169 (ABI) or Silencer Select Negative Control #1 siRNA
(ABI) to knock down TLR2 expression and serve as a negative
control respectively, 8 mL INTERFERin (Polyplus) and 200 mL
DMEM. After a 10 minute incubation period at room tempera-
ture, 200 mL of the transfection solution was added to each well of
a 6 well plate containing A549 cells, and 200 mL DMEM was
added to untreated control wells. Plates were then incubated at
37uC, in humidified 5% CO2 for 48 hours. Tissue culture plates
containing transfected A549 cells were washed 3 times with 2 mL
Iscove’s medium, and M. abscessus 390S DmmpL4b was added to
wells at a concentration of 1610
7 CFU/well, in 2 mL Is-
cove’s+5% human serum. Control wells received only 2 mL
Iscove’s medium+5% human serum. Plates were then incubated at
37uC, in humidified 5% CO2 for 8 hours. The wells were then
washed three times with Iscove’s medium, prior to being lysed with
350 mL Qiagen RLT buffer (Qiagen). Lysates were placed in
RNAse free tubes (VWR) and frozen 280uC for later RNA
isolation.
RNA was isolated using the RNeasy kit. The HbD2 primer/
probe sequences (see above), the ABI TLR2 gene expression assay
Hs00152932_m1, and the ABI Human Eukaryotic 18 s rRNA
Taqman Gene Expression Assay (Endogenous Control) were used
for detection of HbD2, TLR2 and 18 s, respectively. qRTPCR of
the RNA was performed as described above. A no template
control was included to verify that amplification only took place in
reactions containing RNA. Thermocycling conditions were as
described above. Relative quantity was determined using the
2
2DDCT method [20], using the untreated control as the calibrator
sample for HbD2 expression and the control treated with
scrambled RNA as the control sample for TLR2 expression.
Western blot analysis
Transfected A549 cells were lysed with 300 mL RIPA buffer
(Pierce). Lysates were placed in sterile tubes (VWR), and frozen
280uC for later analysis. Protein concentration was measured
using the BCA protein Assay (Thermo). 50 mg protein was
incubated in 16 Laemmli Sample Buffer (Biorad) at 95uCf o r
5 minutes, and separated by electrophoresis on a 10% Tris-HCL
ReadyGel (Biorad) in Tris/Glycine/SDS Buffer (Biorad). The
protein was then transferred to a 0.2 mm nitrocellulose mem-
brane (Biorad) in 106 Tris/Glycine Buffer (Biorad)+20%
methanol (Fisher), overnight at 4uC. The membrane was blocked
with 5% nonfat dry milk in PBS-0.05% tween (PBS, Gibco;
Tween-20, Sigma), for one hour at room temperature. Following
3 washes in PBS-0.05% tween, the membrane was cut such that
the actin bands were on one half and the TLR2 bands on the
other. The TLR2 membrane was incubated in 2 mg/mL Rabbit
polyclonal antibody toTLR2 (Abcam), and the actin membrane
in 0.5 mg/mL mouse monoclonal antibody to actin (Abcam), in
3% BSA- PBS-0.05% Tween (BSA, EM Science), for one hour at
room temperature. Following 3 washes in PBS-0.05% Tween, the
TLR2 membrane was incubated in 1:250,000 goat anti-rabbit
IgG+HRP (Thermo), and the actin membrane in 1:250,000 goat
anti-mouse IgG+HRP (Thermo), in 5% nonfat dry milk in PBS-
0.05% tween, for one hour at room temperature. After 3 washes
in PBS-0.05% Tween, the membranes were blotted dry on
bibulous paper before 1 minute of incubation with Supersignal
West Dura Extended Duration Substrate (Thermo). The
membranes were dried with bibulous paper, and exposed to
blue x-ray film (Phoenix).
Results
A549 alveolar epithelial cells generate an innate immune
response to M. abscessus variants lacking GPL
We have previously demonstrated that human macrophages
recognize M. abscessus variants lacking GPL via TLR2, resulting in
release of the proinflammatory cytokine TNFa. One class of M.
abscessus surface molecules involved in this interaction are the
phosphatidyl-myo-inositol mannosides which we have demonstrat-
ed are ‘‘masked’’ in M. abscessus variants expressing GPL [9]. To
determine whether the innate immune system of respiratory
epithelial cells recognizes M. abscessus rough variants lacking GPL,
we challenged A549 cells with the M. abscessus rough variants 390R
and 390V, and the M. abscessus smooth variant 390S which
expresses GPL [8,9]. HbD2, which is expressed by A549 cells in
response to TLR stimulation [18], was assessed by real-time PCR.
IL-1b stimulation without M. abscessus infection was included as
one control because it stimulates HbD2 expression by a signaling
pathway which is independent from the TLR signaling pathway
[16]. MALP-2 stimulation without M. abscessus infection was
Figure 1. A549 cells increase HbD2 gene expression in
response to M. abscessus variants lacking GPL, but not the M.
abscessus 390S variant expressing GPL. A549 cell monolayers were
uninfected or challenged with M. abscessus variants 390R or 390S. In
addition, some uninfected A549 cell monolayers were treated with IL1b
or MALP-2 as controls for the ability of A549 cells to upregulate HbD2
gene expression. After 8 hours, HbD2 gene expression was quantified
by real-time PCR. The results of real-time PCR are expressed as the
relative fold increase in HBD2 gene expression over that of the
untreated group and presented as mean +/2 SD of measurements from
the same experiment performed in triplicate. * 390S versus 390R and
390V; P,0.05, t-test.
doi:10.1371/journal.pone.0029148.g001
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signaling pathway [21]. Both IL-1b and MALP-2 stimulation
resulted in substantial increases in HbD2 gene expression relative
to untreated controls. Both M. abscessus rough variants lacking
GPL also stimulated a significant increase in HbD2 gene
expression over untreated control and M. abscessus 390S. In
contrast, M. abscessus 390S did not increase HbD2 gene expression
above untreated control (Figure 1). These results indicate that M.
abscessus rough variants stimulate the innate immune response of
respiratory epithelial cells.
A M. abscessus GPL deletion mutant derived from the
390S smooth variant regains the ability to stimulate the
A549 alveolar epithelial cell innate immune response
We next sought to determine whether the previously characterized
deletion mutant 390SDmmpL4b, which does not express GPL [13],
gains the ability to stimulate the innate immune response of
respiratory epithelial cells. When challenged with the 390SDmmpL4b
variant, A549 cells responded with increased expression of HbD2 to a
level comparable to that seen with the rough variant 390V
(Figure 2A). M. abscessus 390V is the ideal comparator strain in this
assay because it is a spontaneous mutant which arose on subculture of
390S, acquiring the rough phenotype and losing its ability to express
significant quantities of GPL [8]. In addition, the complemented
390SDmmpL4b strain, which has regained the smooth phenotype and
the ability to produce GPL [13], lacks the ability to stimulate A549
cell HbD2 gene expression (Figure 2B). Taken together, these results
indicate that M. abscessus GPL expression interferes with activation of
the respiratory epithelial cell innate immune response.
TLR2 siRNA treatment decreases expression of TLR2 in
both uninfected and infected A549 alveolar epithelial
cells
In a prior study we demonstrated that human macrophage
TLR2 mediates the macrophage innate immune response to M.
abscessus rough variants [9]. As the first step in assessing the role of
TLR2 in the respiratory epithelial response to M. abscessus,w e
examined the effect of TLR2 siRNA on TLR2 gene expression in
uninfected A549 cells. TLR2 siRNA treatment resulted in a 76%
reduction in TLR2 gene transcript relative to cells treated with
scrambled RNA (Figure 3A). This was accompanied by a decrease
in TLR2 protein as assessed by Western blotting (Figure 3B).
When A549 cells were infected with M. abscessus 390SDmmpL4b,
baseline expression of TLR2 increased. TLR2 siRNA treatment,
however, resulted in decreased TLR2 gene expression, while
treatment with scrambled RNA did not (Figure 3C). These results
indicate that siRNA TLR2 treatment is able to reduce TLR2 gene
expression in both uninfected and infected A549 cells.
TLR2 siRNA treatment decreases expression of HbD2
gene transcript in A549 alveolar epithelial cells in
response to challenge with the M. abscessus
390SDmmpL4b deletion mutant
To determine whether the M. abscessus 390SDmmpL4b deletion
mutant signals the innate immune response of A549 cells through
TLR2, A549 cells were treated with scrambled RNA or TLR2
siRNA and then infected with this variant. Treatment with TLR2
siRNA, but not scrambled RNA, was associated with a significant
reduction in HbD2 gene expression compared with cells receiving
Figure 2. A M. abscessus 390SDmmpL4b deletion mutant lacking GPL has acquired the ability to stimulate HBD2 gene expression in
A549 cells. (A) A549 cell monolayers were uninfected or challenged with M. abscessus variants 390V, 390S or 390SDmmpL4b, a deletion mutant
lacking the mmpL4b gene which is a critical component of the GPL biosynthetic pathway. The results of real-time PCR are expressed as the relative
fold increase in HbD2 gene expression over that of the untreated group and presented as mean +/2 SD of measurements from the same experiment
performed in triplicate. * 390SDmmpL4b mutant vs 390S wild type; P,0.05, t-test. (B) A549 cell monolayers were uninfected or challenged with M.
abscessus 390SDmmpL4b, or the complemented 390SDmmpL4b mutant. After 8 hours, HbD2 gene expression was quantified by real-time PCR. The
results of real-time PCR are expressed as the relative fold increase in HbD2 gene expression over that of the untreated group and presented as mean
+/2 SD of measurements from the same experiment performed in triplicate. * 390SDmmpL4b complemented versus 390SDmmpL4b mutant; P,0.05,
t-test.
doi:10.1371/journal.pone.0029148.g002
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variants lacking GPL signal the respiratory epithelial cell response
through TLR2.
IL-8 release by A549 alveolar epithelial cells in response
to the M. abscessus 390SDmmpL4b deletion mutant is
mediated by TLR2
IL-8 has been used as a readout for TLR2 stimulation of
respiratory epithelial cells. To replicate the HbD2 experiments
using a different method, we assessed the response of A549 cells to
M. abscessus 390SDmmpL4b by measuring IL-8 release. In addition,
we assessed the role of TLR2 in mediating this response using a
TLR2 blocking antibody which we have previously used to block
the human macrophage TLR2 response to M. abscessus variants
[9]. In this experiment 390SDmmpL4b stimulated release of
substantial quantities of IL-8 which was blocked by preincubation
with anti-TLR2 antibody, but not isotype control antibody
(Figure 5). These results are consistent with the results obtained
using HbD2 gene expression as a readout for stimulation of TLR2
by M. abscessus 390SDmmpL4b.
GPL expression by M. abscessus 390S prevents TLR2
signaling in BEAS 2B cells as measured by IL-8 release
To insure that our findings with A549 cells have relevance to
other respiratory epithelial cells, we assessed the interaction of M.
abscessus variants with BEAS 2B cells. These cells are a well-
characterized SV40 immortalized cell line derived from normal
human bronchial epithelium. They possess TLR2 receptors and
release IL-8 in response to TLR2 stimulation [18,19]. In these
experiments we measured IL-8 release in response to our M.
abscessus rough variants 390R and 390V, and the smooth variant
390S which expresses GPL. Both M. abscessus rough variants
lacking GPL stimulated a significant increase in IL-8 release
compared to the untreated control and M. abscessus 390S
(Figure 6A). Furthermore, M. abscessus 390SDmmpL4 regained
the ability to stimulate IL-8 release via TLR2 (Figure 6B). These
Figure 3. TLR2 siRNA treatment decreases TLR2 gene expression in uninfected and M. abscessus -infected A549 cells. As a first step in
assessing the role of TLR2 in respiratory epithelial responses to M. abscessus, the effect of transfection of A549 cells with TLR2 siRNA on TLR2 gene
expression was assessed. (A) Uninfected A549 cells were transfected with scrambled RNA or TLR2 siRNA. After 48 h TLR2 gene expression was
quantified by real-time PCR. The results of real-time PCR are expressed as the relative difference in TLR2 gene expression using the A549 monolayers
receiving scrambled RNA as the reference, with data presented as mean +/2 SD of measurements from the same experiment performed in triplicate.
*TLR2 transfected cells versus cells receiving scrambled RNA P,0.05, t-test. (B) Western blotting of A549 cell extracts from (A) demonstrates
decreased TLR2 in cells treated with TLR2 siRNA. (C) A549 cell monolayers were either untreated or transfected with RNA, and either uninfected or
challenged with M. abscessus 390SDmmpL4b. TLR2 gene expression was quantified by real-time PCR. The results of real-time PCR are expressed as the
relative difference in TLR2 gene expression using uninfected A549 monolayers receiving scrambled RNA as the reference, with data presented as
mean +/2 SD of measurements from the same experiment performed in triplicate. * TLR2 siRNA + M. abscessus 390SDmmpL4b versus scrambled RNA
+ M. abscessus 390SDmmpL4b; P,0.05, t-test.
doi:10.1371/journal.pone.0029148.g003
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through spontaneous mutation, or targeted deletion of a gene
critical for GPL formation, gain the ability to stimulate TLR2 in
respiratory epithelial cells. These results are consistent with our
previous findings which indicate that GPL masks underlying
bioactive cell wall molecules capable of interacting with host cells
[9].
Discussion
In this study we demonstrate that a naturally occurring GPL-
expressing smooth M. abscessus variant (390S) does not stimulate
the innate immune response of respiratory epithelial cells, while
rough variants lacking GPL (390R, 390V) stimulate respiratory
epithelial cells through TLR2, resulting in gene expression of the
downstream effector molecule HbD2 and release of IL-8.
Furthermore, loss of M. abscessus 390S GPL through targeted
deletion of the mmpL4b gene critical for GPL synthesis [13]
converts the bacterium to a phenotype capable of stimulating
respiratory epithelial TLR2. These results are in keeping with our
prior studies using macrophages, which demonstrate that loss of
GPL through either spontaneous mutation, physical removal, or
targeted gene deletion converts M. abscessus to an immunostimu-
latory phenotype capable of stimulating release of TNFa via
interaction with TLR2 [9,13]. In previous studies we have
provided evidence that GPL masks underlying M. abscessus cell
wall lipids which are known TLR2 ligands [9].
There has been increasing recognition of the role that
respiratory epithelium plays in host innate immune responses to
bacterial pathogens. The human innate immune response is the
immediate response engendered by the host to a foreign antigen.
In the lung, both alveolar macrophages, and respiratory epithelial
cells are central to the innate immune response [15]. It is distinct
from adaptive or cell-mediated immunity which takes time to
develop and involves antigen presentation to T- lymphocytes,
which orchestrate the subsequent host response. Because M.
abscessus is primarily an opportunistic pathogen, it is probable that
innate immune responses are important in preventing infection
with this organism. The TLRs, which mediate the host innate
immune response, are present on macrophages, dendritic cells and
respiratory epithelial cells lining the lung. These receptors
recognize pathogen-associated molecular patterns, which are
conserved motifs expressed by microorganisms, but not by higher
eukaryotes. In the case of mycobacteria, bacterial lipopeptides in
the cell wall are recognized by host cell TLR2/TLR1 heterodi-
mers [22,23]. We have previously demonstrated that M. abscessus
expresses one type of these surface components, the phosphatidyl-
myo-inositol mannosides [9], which stimulate the macrophage
innate immune response via TLR2 signaling.
Figure 4. TLR2 siRNA treatment decreases HbD2 gene expres-
sion in A549 cells challenged with the M. abscessus 390S
mmpL4b deletion mutant. A549 cells were transfected with
scrambled RNA or TLR2 siRNA for 48 h with some cell monolayers
then challenged with M. abscessus 390SDmmpL4b. After 8 h, HbD2
gene expression was quantified by real-time PCR. The results of real-
time PCR are expressed as the relative change in HbD2 gene expression
over that of the untreated, uninfected group and presented as mean
+/2 SD of measurements from the same experiment performed in
triplicate. * TLR2 siRNA + M. abscessus 390SDmmpL4b versus scrambled
RNA + M. abscessus 390SDmmpL4b; P,0.05, t-test.
doi:10.1371/journal.pone.0029148.g004
Figure 5. Antibody to TLR2 decreases IL-8 release from A549
cells in response to the M. abscessus 390SDmmpL4b deletion
mutant. A549 cell monolayers were preincubated with antibody to
TLR2 or isotype control antibody and then received no bacteria or were
challenged with the M. abscessus 390SDmmpL4b deletion mutant.
Culture supernates were collected after 8 h and assayed by ELISA for IL-
8. Data are means 6 SEM of two experiments done in triplicate. *
390SDmmpL4b + anti-TLR2 antibody versus 390SDmmpL4b alone and
390SDmmpL4b + isotype antibody; p,0.01, t-test.
doi:10.1371/journal.pone.0029148.g005
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of pro-inflammatory cytokines [23]. Ligand binding to TLRs
present on respiratory epithelial cells leads to expression of the
chemokine IL-8 involved in recruitment of circulating neutrophils
to sites of infection/inflammation in the lung [24]. Stimulation of
respiratory epithelial cells with the inflammatory cytokine IL-1b
also leads to release of IL-8 through a mechanism that bypasses the
TLR signaling [25]. In addition to IL-8, respiratory epithelial cells
upregulate expression of the antimicrobial peptide HbD2 both in
response to TLR engagement and IL1b stimulation [26]. Thus,
there are two mechanisms by which respiratory epithelial cells are
stimulated to express HbD2 and IL-8 in response to bacterial
pathogens. In one mechanism, alveolar macrophages present in
lung alveoli recognize bacteria via TLRs leading to expression of
IL-1b. This in turn activates respiratory epithelial cells in the
immediate vicinity to upregulate expression of HbD2 and release
IL-8. This mechanism does not involve binding TLRs on
respiratory epithelial cells [27]. In the second mechanism, direct
engagement of TLRs at various levels in the respiratory tract by
bacterial ligands results in a signaling cascade leading to HbD2
expression by respiratory epithelial cells [26] and release of IL-8.
Thus, in upper portions of the respiratory tract where mucociliary
clearance is operating and alveolar macrophages are absent,
respiratory epithelial cells are the primary sentinels, sampling the
airways for bacterial pathogens via TLRs on their surface. If
bacteria are able to survive the upper airways and enter the
alveoli, respiratory epithelial HbD2 expression and IL-8 release in
response to direct TLR2 stimulation is augmented by IL-1b
released from alveolar macrophages. In addition to inducing
HbD2 by alveolar epithelial cells, IL-1b stimulates cell-mediated
immune responses such as activation of B and T lymphocytes.
This sequence of events is consistent with a vigorous host defense
being mounted in the alveoli if upper airway defense mechanisms
are breached.
A549 cells are an alveolar epithelial tumor cell line used to study
respiratory epithelial cellular responses [28]. Because freshly
explanted human alveolar type II cells are difficult to obtain,
A549 cells are a useful surrogate for the study of respiratory
epithelial cell responses at the level of the alveolus [29]. Of
relevance to our study is the fact that these cells have been used to
study the interaction of mycobacteria with respiratory epithelium
[30–34]. Also relevant to our study are previous reports indicating
that A549 cells express TLR2, express HbD2 in response to IL1-b
and TLR2 stimulation [16], and express HbD2 in response to M.
tuberculosis infection [35]. In addition, evidence suggests that HbD2
possesses antimicrobial activity against M. tuberculosis when
expressed by host cells coming into contact with this bacterium
[36]. In addition to A549 cells, we examined the interaction of M.
abscessus variants with bronchial epithelial BEAS 2B cells. This was
done to assess responses to M. abscessus by a respiratory epithelial
cell from a different site of origin (bronchus) than A459 cells. We
also wanted to replicate our findings in a non-tumor cell line
because genetic changes associated with tumorigenesis can alter
cellular responses. We found that both cell lines responded
similarly to M. abscessus variants.
Our study demonstrates that M. abscessus GPL-expressing
smooth variants are not recognized by TLRs present on
respiratory epithelial cells. This is consistent with the hypothesis
we have put forth which suggests that M. abscessus smooth variants
are a colonizing phenotype by virtue of characteristics which
include sliding motility, biofilm formation, and the ability to avoid
detection by TLR2 [8,9,12,17]. These features enable M. abscessus
smooth variants, which are likely the predominant phenotype
found in the environment [37], to colonize ectatic airways and
Figure 6. IL-8 release from BEAS 2B cells in response to M. abscessus variants lacking GPL is mediated by TLR2. (A) BEAS 2B bronchial
epithelial cells received no bacteria or were challenged with M. abscessus variants 390R, 390S and 390V. Culture supernates were collected after 8 h
and assayed by ELISA for IL-8. Data are means 6 SEM of two experiments done in triplicate. * 390S versus 390R and 390V; p,0.01, t-test. (B) BEAS 2B
bronchial epithelial cells were preincubated with no antibody, antibody to TLR2 or isotype control antibody. Monolayers then received no bacteria or
were challenged with the M. abscessus 390SDmmpL4b deletion mutant or the 390SDmmpL4b complemented mutant. Culture supernates were
collected after 8 h and assayed by ELISA for IL-8. Data are means 6 SEM of two experiments done in triplicate. * 390SDmmpL4b deletion mutant +
anti-TLR2 antibody versus 390SDmmpL4b deletion mutant alone and versus 390SDmmpL4b deletion mutant + isotype antibody; p,0.01.
* 390SDmmpL4b complemented mutant versus 390SDmmpL4b deletion mutant; p,0.01.
doi:10.1371/journal.pone.0029148.g006
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previously demonstrated that spontaneous loss of GPL converts M.
abscessus to an immunostimulatory phenotype capable of invading
and replicating in fibroblasts and macrophages [8,9,12,13,17]. We
now extend our observations by demonstrating that M. abscessus
variants lacking GPL are recognized by TLR2 on respiratory
epithelial cells resulting in release of IL-8 and expression of HbD2.
Based on these results and those of prior studies, we propose that
M. abscessus variants expressing GPL are able to colonize abnormal
upper airways in patients with bronchiectasis without evoking an
immune response. This enables the bacteria to establish a foothold
in the lung. Spontaneous mutants lacking GPL, arising from these
colonizing bacteria, then enter the alveolar space where they cause
invasive lung infection and provoke an inflammatory response. It
is possible that additional defects in the immune recognition and/
or response are present in subsets of patients with bronchiectasis
which result in an inability to clear these rough variants once
invasive infection is established in the lung parenchyma. This is
currently being investigated in our laboratory.
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